Cefmenoxime
Intramuscular, intravenous | |
ATC code | |
---|---|
Pharmacokinetic data | |
Bioavailability | 100% (given IM) |
Protein binding | 50% to 70% |
Metabolism | Negligible |
Elimination half-life | 1 hour |
Excretion | Kidney, unchanged |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Cefmenoxime is a third-generation cephalosporin antibiotic.[citation needed]
References
External links
- Diseases Database (DDB): 30892
- Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot. 48 (5): 602–9. PMID 7637194.
- Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia". Ann Pharmacother. 28 (3): 384–9. S2CID 29444681.
- Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture". Ophthalmologica. 208 (5): 262–6. PMID 7816419.